The strong predictive ability of an IL-10-sensitive inflammatory monocyte signature (CD14, IL1A, IL1B, OSM, PTGS2, IL6, CCL2/3 and CXCL1/2) emphasises a surprising and underestimated extent of IL-10 non-responsiveness in IBD. The gene discussed is CCL2; the disease is inflammatory bowel disease.